HP

HealthInvest Partners Portfolio holdings

AUM $234M
1-Year Return 10.88%
This Quarter Return
+8.82%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$80.2M
AUM Growth
+$15M
Cap. Flow
+$10.7M
Cap. Flow %
13.37%
Top 10 Hldgs %
98.34%
Holding
15
New
5
Increased
2
Reduced
4
Closed
4

Top Buys

1
ELV icon
Elevance Health
ELV
+$10.4M
2
LH icon
Labcorp
LH
+$7.06M
3
PFE icon
Pfizer
PFE
+$6.88M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$6.82M
5
BIIB icon
Biogen
BIIB
+$6.78M

Top Sells

1
AET
Aetna Inc
AET
+$11.4M
2
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
+$5.47M
3
GNC
GNC Holdings, Inc.
GNC
+$3.11M
4
ANIK icon
Anika Therapeutics
ANIK
+$2.79M
5
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
+$2.1M

Sector Composition

1 Healthcare 100%
2 Financials 0%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ELV icon
1
Elevance Health
ELV
$69.4B
$10.4M 12.95%
+55,200
New +$10.4M
MCK icon
2
McKesson
MCK
$87.9B
$10.4M 12.95%
63,100
+12,100
+24% +$1.99M
COR icon
3
Cencora
COR
$56.5B
$10.4M 12.93%
109,700
-16,300
-13% -$1.54M
CRL icon
4
Charles River Laboratories
CRL
$7.49B
$7.1M 8.86%
70,212
-15,400
-18% -$1.56M
LH icon
5
Labcorp
LH
$22.9B
$7.06M 8.8%
+53,311
New +$7.06M
GILD icon
6
Gilead Sciences
GILD
$141B
$6.91M 8.61%
97,600
-19,400
-17% -$1.37M
PFE icon
7
Pfizer
PFE
$137B
$6.88M 8.58%
+215,859
New +$6.88M
LGND icon
8
Ligand Pharmaceuticals
LGND
$3.19B
$6.82M 8.51%
+90,089
New +$6.82M
BIIB icon
9
Biogen
BIIB
$21.3B
$6.78M 8.46%
+25,000
New +$6.78M
ANIK icon
10
Anika Therapeutics
ANIK
$126M
$6.17M 7.69%
125,000
-56,573
-31% -$2.79M
ICCC icon
11
ImmuCell
ICCC
$53.8M
$1.34M 1.66%
182,133
+13,810
+8% +$101K
GNC
12
DELISTED
GNC Holdings, Inc.
GNC
– –
-422,955
Closed -$3.11M
ACHN
13
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
– –
-497,807
Closed -$2.1M
AET
14
DELISTED
Aetna Inc
AET
– –
-89,000
Closed -$11.4M
OSIR
15
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
– –
-1,140,222
Closed -$5.47M